In HNC, CYP2C19 polymorphisms have also been linked to increased cancer susceptibility, with poor-metabolizer alleles (e.g., CYP2C192) showing a significant association with higher risk of developing squamous cell carcinoma (26). This evidence concerns the gene CYP2C19 and squamous cell carcinoma.